Professor Rotem Sorek, PhD, from the Department of Molecular Genetics, Weizmann Institute of Science for his proposal, Beyond CRISPR: Genomic elucidation of bacterial immune systems, towards new biomedical tools.
Professor Karen B. Avraham, PhD from the Department of Human Molecular Genetics & Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, for her proposal, Non-coding RNAs and Methylation of the Neurosensory Hair Cell: Implications for Hereditary Hearing Loss.
Dr. Liran Shlush, MD PhD, Senior Scientist, Department for Immunology, The Weizmann Institute for Science, for her proposal: Leukemia early evolution- diagnosis and treatment of Pre-leukemia.
Professor Roy Kishony from the Technion Israel Institute of Technology, for his proposal: “Predicting antibiotic resistance and treatment failure in urinary tract infections.”
Professor Yuval Dor of the Hebrew University Medical School for his research "Project FREEDOME: analysis of cell death in specific human tissues using the
methylome of cell free, circulating DNA."
Professor Ido Amit, Principal Investigator in the Amit Lab for Immuno-genomics, Department of Immunology at the Weizmann Institute, Rehovot, Israel, was chosen for his research project: Uncovering Principles and Mechanisms of Blood Development using Massively Parallel Single Cell RNA-seq.
Professor Yair Reisner, Henry Drake chair in Transplantation Immunology of the Department of Immunology, at the Weizmann Institute, Rehovot, Israel, was chosen for his research project: Canalicular State Embryonic Lung Cell Transplantation as a Novel Source for Lung Regeneration: The Analogy between Bone Marrow and Lung Progenitors and Their Respective Niches.
Dr. Tsvee Lapidot is a Professor in the Department of Immunology of the Weizmann Institute of Science. He was chosen for the Beutler Award for his research entitled Regulation of normal and leukemic human stem cells by oncogenic microRNAs miR-126 and miR-155.
Professor Karl Skorecki, Director, Research and Medical Development, Rambam Health Care Campus.
Professor Gideon Rechavi, Head of the Sheba Cancer Research Center at Sheba Medical Center, for his research on the role of m6A RNA methylation in obesity, diabetes, and cancer.